Abstract
Tumor lymphatics play a key role in cancer progression as they are solely responsible for transporting malignant cells to regional lymph nodes (LNs), a process that precedes and promotes systemic lethal spread. It is broadly accepted that tumor lymphatic sprouting is induced mainly by soluble factors derived from tumor-associated macrophages (TAMs) and malignant cells. However, emerging evidence strongly suggests that a subset of TAMs, myeloid-lymphatic endothelial cell progenitors (M-LECP), also contribute to the expansion of lymphatics through both secretion of paracrine factors and a self-autonomous mode. M-LECP are derived from bone marrow (BM) precursors of the monocyte-macrophage lineage and characterized by unique co-expression of markers identifying lymphatic endothelial cells (LEC), stem cells, M2-type macrophages, and myeloid-derived immunosuppressive cells. This review describes current evidence for the origin of M-LECP in the bone marrow, their recruitment tumors and intratumoral trafficking, similarities to other TAM subsets, and mechanisms promoting tumor lymphatics. We also describe M-LECP integration into preexisting lymphatic vessels and discuss potential mechanisms and significance of this event. We conclude that improved mechanistic understanding of M-LECP functions within the tumor environment may lead to new therapeutic approaches to suppress tumor lymphangiogenesis and metastasis to lymph nodes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahn GO, Tseng D, Liao CH, Dorie MJ, Czechowicz A, Brown JM (2010) Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc Natl Acad Sci USA 107:8363–8368
Albeniz I, Turker-Sener L, Bas A, Kalelioglu I, Nurten R (2012) Isolation of hematopoietic stem cells and the effect of CD38 expression during the early erythroid progenitor cell development process. Oncol Lett 3:55–60
Ambrosi DJ, Rasmussen TP (2005) Reprogramming mediated by stem cell fusion. J Cell Mol Med 9:320–330
Angeli V, Randolph GJ (2006) Inflammation, lymphatic function, and dendritic cell migration. Lymphat Res Biol 4:217–228
Beasley NJ, Prevo R, Banerji S, Leek RD, Moore J, van Trappen P et al (2002) Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62:1315–1320
Bellingan GJ, Xu P, Cooksley H, Cauldwell H, Shock A, Bottoms S et al (2002) Adhesion molecule-dependent mechanisms regulate the rate of macrophage clearance during the resolution of peritoneal inflammation. J Exp Med 196:1515–1521
Betterman KL, Harvey NL (2016) The lymphatic vasculature: development and role in shaping immunity. Immunol Rev 271:276–292
Bjorndahl MA, Cao R, Burton JB, Brakenhielm E, Religa P, Galter D et al (2005) Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res 65:9261–9268
Bogos K, Renyi-Vamos F, Dobos J, Kenessey I, Tovari J, Timar J et al (2009) High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer. Clin Cancer Res 15:1741–1746
Bron S, Henry L, Faes-Van't Hull E, Turrini R, Vanhecke D, Guex N et al (2016) TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancer. Oncoimmunology 5:e1073882
Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF et al (2016) Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun 7:12150
Brown M, Assen FP, Leithner A, Abe J, Schachner H, Asfour G et al (2018) Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice. Science 359:1408–1411
Bryant CE, Spring DR, Gangloff M, Gay NJ (2010) The molecular basis of the host response to lipopolysaccharide. Nat Rev Microbiol 8:8–14
Burton JB, Priceman SJ, Sung JL, Brakenhielm E, An DS, Pytowski B et al (2008) Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer Res 68:7828–7837
Butler KL, Clancy-Thompson E, Mullins DW (2017) CXCR3(+) monocytes/macrophages are required for establishment of pulmonary metastases. Sci Rep 7:45593
Buttler K, Lohrberg M, Gross G, Weich HA, Wilting J (2016) Integration of CD45-positive leukocytes into newly forming lymphatics of adult mice. Histochem Cell Biol 145:629–636
Cao C, Lawrence DA, Strickland DK, Zhang L (2005) A specific role of integrin Mac-1 in accelerated macrophage efflux to the lymphatics. Blood 106:3234–3241
Cecco S, Aliberti M, Baldo P, Giacomin E, Leone R (2014) Safety and efficacy evaluation of albumin-bound paclitaxel. Expert Opin Drug Saf 13:511–520
Changming W, Xin L, Hua T, Shikun W, Qiong X, Zhigeng Z et al (2011) Monocytes can be induced to express lymphatic phenotypes. Lymphology 44:48–53
Chen P, Huang Y, Bong R, Ding Y, Song N, Wang X et al (2011) Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner. Clin Cancer Res 17:7230–7239
Chen Y, Tan W, Wang C (2018) Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial-mesenchymal transition. Onco Targets Ther 11:3817–3826
Cheng Z, Taylor B, Ourthiague DR, Hoffmann A (2015) Distinct single-cell signaling characteristics are conferred by the MyD88 and TRIF pathways during TLR4 activation. Sci Signal 8:ra69
Cho CH, Koh YJ, Han J, Sung HK, Jong LH, Morisada T et al (2007) Angiogenic role of LYVE-1-positive macrophages in adipose tissue. Circ Res 100:e47–e57
Claesson-Welsh L (2015) Vascular permeability--the essentials. Ups J Med Sci 120:135–143
Conrad C, Niess H, Huss R, Huber S, von Luettichau I, Nelson PJ et al (2009) Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo. Circulation 119:281–289
Corliss BA, Azimi MS, Munson JM, Peirce SM, Murfee WL (2016) Macrophages: an inflammatory link between angiogenesis and lymphangiogenesis. Microcirculation 23:95–121
Cueni LN, Detmar M (2008) The lymphatic system in health and disease. Lymphat Res Biol 6:109–122
Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C et al (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113:1040–1050
Davies PS, Powell AE, Swain JR, Wong MH (2009) Inflammation and proliferation act together to mediate intestinal cell fusion. PLoS One 4:e6530
Delorme B, Basire A, Gentile C, Sabatier F, Monsonis F, Desouches C et al (2005) Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells. Thromb Haemost 94:1270–1279
DeNardo DG, Brennan DJ, Rexhepaj E, Ruffell B, Shiao SL, Madden SF et al (2011) Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov 1:54–67
Ding M, Fu X, Tan H, Wang R, Chen Z, Ding S (2012) The effect of vascular endothelial growth factor C expression in tumor-associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer. Mol Med Rep 6:1023–1029
Dollt C, Becker K, Michel J, Melchers S, Weis CA, Schledzewski K et al (2017) The shedded ectodomain of Lyve-1 expressed on M2-like tumor-associated macrophages inhibits melanoma cell proliferation. Oncotarget 8:103682–103692
Eisemann T, Costa B, Peterziel H, Angel P (2019) Podoplanin positive myeloid cells promote glioma development by immune suppression. Front Oncol 9:187
Elshal MF, Khan SS, Takahashi Y, Solomon MA, McCoy JP Jr (2005) CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood 106:2923–2924
Espagnolle N, Barron P, Mandron M, Blanc I, Bonnin J, Agnel M et al (2014) Specific inhibition of the VEGFR-3 tyrosine kinase by SAR131675 reduces peripheral and tumor associated immunosuppressive myeloid cells. Cancers (Basel) 6:472–490
Ferrand J, Noel D, Lehours P, Prochazkova-Carlotti M, Chambonnier L, Menard A et al (2011) Human bone marrow-derived stem cells acquire epithelial characteristics through fusion with gastrointestinal epithelial cells. PLoS One 6:e19569
Fleming TJ, Fleming ML, Malek TR (1993) Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol 151:2399–2408
Gangloff M, Weber AN, Gay NJ (2005) Conserved mechanisms of signal transduction by toll and toll-like receptors. J Endotoxin Res 11:294–298
Gordon EJ, Rao S, Pollard JW, Nutt SL, Lang RA, Harvey NL (2010) Macrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferation. Development 137:3899–3910
Gough PJ, Gordon S, Greaves DR (2001) The use of human CD68 transcriptional regulatory sequences to direct high-level expression of class a scavenger receptor in macrophages in vitro and in vivo. Immunology 103:351–361
Guo YC, Chiu YH, Chen CP, Wang HS (2018) Interleukin-1beta induces CXCR3-mediated chemotaxis to promote umbilical cord mesenchymal stem cell transendothelial migration. Stem Cell Res Ther 9:281
Hall KL, Volk-Draper LD, Flister MJ, Ran S (2012) New model of macrophage acquisition of the lymphatic endothelial phenotype. PLoS One 7:e31794
Hammerling GJ, Ganss R (2006) Vascular integration of endothelial progenitors during multistep tumor progression. Cell Cycle 5:509–511
Hamrah P, Chen L, Cursiefen C, Zhang Q, Joyce NC, Dana MR (2004) Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva. Exp Eye Res 79:553–561
Harris AR, Perez MJ, Munson JM (2018) Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression. BMC Cancer 18:718
He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T et al (2002) Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94:819–825
He Y, Rajantie I, Ilmonen M, Makinen T, Karkkainen MJ, Haiko P et al (2004) Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res 64:3737–3740
Hestdal K, Ruscetti FW, Ihle JN, Jacobsen SE, Dubois CM, Kopp WC et al (1991) Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol 147:22–28
Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H et al (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423–1425
Jeon BH, Jang C, Han J, Kataru RP, Piao L, Jung K et al (2008) Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer. Cancer Res 68:1100–1109
Ji RC (2012) Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesis. Cell Mol Life Sci 69:897–914
Jiang S, Bailey AS, Goldman DC, Swain JR, Wong MH, Streeter PR et al (2008) Hematopoietic stem cells contribute to lymphatic endothelium. PLoS One 3:e3812
Johansson CB, Youssef S, Koleckar K, Holbrook C, Doyonnas R, Corbel SY et al (2008) Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation. Nat Cell Biol 10:575–583
Jussila L, Alitalo K (2002) Vascular growth factors and lymphangiogenesis. Physiol Rev 82:673–700
Jutila MA, Kroese FG, Jutila KL, Stall AM, Fiering S, Herzenberg LA et al (1988) Ly-6C is a monocyte/macrophage and endothelial cell differentiation antigen regulated by interferon-gamma. Eur J Immunol 18:1819–1826
Karikoski M, Marttila-Ichihara F, Elima K, Rantakari P, Hollmen M, Kelkka T et al (2014) Clever-1/stabilin-1 controls cancer growth and metastasis. Clin Cancer Res 20:6452–6464
Kataru RP, Jung K, Jang C, Yang H, Schwendener RA, Baik JE et al (2009) Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113:5650–5659
Kawada K, Taketo MM (2011) Significance and mechanism of lymph node metastasis in cancer progression. Cancer Res 71:1214–1218
Kerjaschki D, Huttary N, Raab I, Regele H, Bojarski-Nagy K, Bartel G et al (2006) Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 12:230–234
Kim KE, Koh YJ, Jeon BH, Jang C, Han J, Kataru RP et al (2009) Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm. Am J Pathol 175:1733–1745
Kubota Y, Takubo K, Shimizu T, Ohno H, Kishi K, Shibuya M et al (2009) M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J Exp Med 206:1089–1102
Lee JY, Park C, Cho YP, Lee E, Kim H, Kim P et al (2010) Podoplanin-expressing cells derived from bone marrow play a crucial role in postnatal lymphatic neovascularization. Circulation 122:1413–1425
Lee SJ, Park C, Lee JY, Kim S, Kwon PJ, Kim W et al (2015) Generation of pure lymphatic endothelial cells from human pluripotent stem cells and their therapeutic effects on wound repair. Sci Rep 5:11019
Lin EY, Nguyen AV, Russell RG, Pollard JW (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193:727–740
Lin X, Zheng W, Liu J, Zhang Y, Qin H, Wu H et al (2013) Oxidative stress in malignant melanoma enhances tumor necrosis factor-alpha secretion of tumor-associated macrophages that promote cancer cell invasion. Antioxid Redox Signal 19:1337–1355
Liu Y, Poon RT, Hughes J, Feng X, Yu WC, Fan ST (2005) Chemokine receptors support infiltration of lymphocyte subpopulations in human hepatocellular carcinoma. Clin Immunol 114:174–182
Lohela M, Saaristo A, Veikkola T, Alitalo K (2003) Lymphangiogenic growth factors, receptors and therapies. Thromb Haemost 90:167–184
Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M (2013) Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 229:176–185
Mantovani A, Marchesi F, Porta C, Sica A, Allavena P (2007) Inflammation and cancer: breast cancer as a prototype. Breast 16(Suppl 2):S27–S33
Maruyama K, Ii M, Cursiefen C, Jackson DG, Keino H, Tomita M et al (2005) Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115:2363–2372
McColl BK, Loughran SJ, Davydova N, Stacker SA, Achen MG (2005) Mechanisms of lymphangiogenesis: targets for blocking the metastatic spread of cancer. Curr Cancer Drug Targets 5:561–571
Movahedi K, Laoui D, Gysemans C, Baeten M, Stange G, Van den Bossche J et al (2010) Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res 70:5728–5739
Murakami M, Zheng Y, Hirashima M, Suda T, Morita Y, Ooehara J et al (2008) VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment. Arterioscler Thromb Vasc Biol 28:658–664
Nerlov C, Graf T (1998) PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev 12:2403–2412
Osada T, Chong G, Tansik R, Hong T, Spector N, Kumar R et al (2008) The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients. Cancer Immunol Immunother 57:1115–1124
Park C, Lee JY, Yoon YS (2011) Role of bone marrow-derived lymphatic endothelial progenitor cells for lymphatic neovascularization. Trends Cardiovasc Med 21:135–140
Pepper MS, Skobe M (2003) Lymphatic endothelium: morphological, molecular and functional properties. J Cell Biol 163:209–213
Perera PY, Mayadas TN, Takeuchi O, Akira S, Zaks-Zilberman M, Goyert SM et al (2001) CD11b/CD18 acts in concert with CD14 and toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 166:574–581
Peters BA, Diaz LA, Polyak K, Meszler L, Romans K, Guinan EC et al (2005) Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 11:261–262
Petrova TV, Koh GY (2018) Organ-specific lymphatic vasculature: from development to pathophysiology. J Exp Med 215:35–49
Pittman K, Kubes P (2013) Damage-associated molecular patterns control neutrophil recruitment. J Innate Immun 5:315–323
Powell AE, Anderson EC, Davies PS, Silk AD, Pelz C, Impey S et al (2011) Fusion between intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming. Cancer Res 71:1497–1505
Pytowski B, Goldman J, Persaud K, Wu Y, Witte L, Hicklin DJ et al (2005) Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst 97:14–21
Qiu H, Cao L, Wang D, Xu H, Liang Z (2013) High levels of circulating CD34+/VEGFR3+ lymphatic/vascular endothelial progenitor cells is correlated with lymph node metastasis in patients with epithelial ovarian cancer. J Obstet Gynaecol Res 39:1268–1275
Ran S, Montgomery KE (2012) Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors. Cancers 4:618–657
Ran S, Volk L, Hall K, Flister MJ (2009) Lymphangiogenesis and lymphatic metastasis in breast cancer. Pathophysiology 17:229–251
Ran S, Wilber A (2017) Novel role of immature myeloid cells in formation of new lymphatic vessels associated with inflammation and tumors. J Leukoc Biol 102:253–263
Randolph GJ, Angeli V, Swartz MA (2005) Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 5:617–628
Religa P, Cao R, Bjorndahl M, Zhou Z, Zhu Z, Cao Y (2005) Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. Blood 106:4184–4190
Reynders N, Abboud D, Baragli A, Noman MZ, Rogister B, Niclou SP et al (2019) The distinct roles of CXCR3 variants and their ligands in the tumor microenvironment. Cell 8:1–17
Riabov V, Yin S, Song B, Avdic A, Schledzewski K, Ovsiy I et al (2016) Stabilin-1 is expressed in human breast cancer and supports tumor growth in mammary adenocarcinoma mouse model. Oncotarget 7:31097–31110
Russo E, Teijeira A, Vaahtomeri K, Willrodt AH, Bloch JS, Nitschke M et al (2016) Intralymphatic CCL21 promotes tissue egress of dendritic cells through afferent lymphatic vessels. Cell Rep 14:1723–1734
Salven P, Mustjoki S, Alitalo R, Alitalo K, Rafii S (2003) VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood 101:168–172
Scallan JP, Zawieja SD, Castorena-Gonzalez JA, Davis MJ (2016) Lymphatic pumping: mechanics, mechanisms and malfunction. J Physiol 594:5749–5768
Schledzewski K, Falkowski M, Moldenhauer G, Metharom P, Kzhyshkowska J, Ganss R et al (2006) Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J Pathol 209:67–77
Schoppmann SF, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C et al (2002) Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161:947–956
Schoppmann SF, Fenzl A, Nagy K, Unger S, Bayer G, Geleff S et al (2006) VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery 139:839–846
Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122:787–795
Skokowa J, Klimiankou M, Klimenkova O, Lan D, Gupta K, Hussein K et al (2012) Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesis. Nat Med 18:1550–1559
Spees JL, Whitney MJ, Sullivan DE, Lasky JA, Laboy M, Ylostalo J et al (2008) Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension. FASEB J 22:1226–1236
Spring H, Schuler T, Arnold B, Hammerling GJ, Ganss R (2005) Chemokines direct endothelial progenitors into tumor neovessels. Proc Natl Acad Sci USA 102:18111–18116
Strachan DC, Ruffell B, Oei Y, Bissell MJ, Coussens LM, Pryer N et al (2013) CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+ T cells. Oncoimmunology 2:e26968
Swartz MA (2014) Immunomodulatory roles of lymphatic vessels in cancer progression. Cancer Immunol Res 2:701–707
Tal O, Lim HY, Gurevich I, Milo I, Shipony Z, Ng LG et al (2011) DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling. J Exp Med 208:2141–2153
Talmadge JE, Donkor M, Scholar E (2007) Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer Metastasis Rev 26:373–400
Tan YZ, Wang HJ, Zhang MH, Quan Z, Li T, He QZ (2014) CD34+ VEGFR-3+ progenitor cells have a potential to differentiate towards lymphatic endothelial cells. J Cell Mol Med 18:422–433
Tawada M, Hayashi S, Ikegame Y, Nakashima S, Yoshida K (2014) Possible involvement of tumor-producing VEGF-A in the recruitment of lymphatic endothelial progenitor cells from bone marrow. Oncol Rep 32:2359–2364
Tawada M, Hayashi S, Osada S, Nakashima S, Yoshida K (2012) Human gastric cancer organizes neighboring lymphatic vessels via recruitment of bone marrow-derived lymphatic endothelial progenitor cells. J Gastroenterol 47:1057–1060
Van’t Hull EF, Bron S, Henry L, Ifticene-Treboux A, Turrini R, Coukos G et al (2014) Bone marrow-derived cells are implicated as a source of lymphatic endothelial progenitors in human breast cancer. Oncoimmunology 3:e29080
Volk-Draper L, Hall K, Griggs C, Rajput S, Kohio P, DeNardo D et al (2014) Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner. Cancer Res 74:5421–5434
Volk-Draper L, Patel R, Bhattarai N, Yang J, Wilber A, DeNardo D et al (2019) Myeloid-derived lymphatic endothelial cell progenitors significantly contribute to lymphatic metastasis in clinical breast Cancer. Am J Pathol 189(11):2269–2292
Volk-Draper LD, Hall KL, Wilber AC, Ran S (2017) Lymphatic endothelial progenitors originate from plastic myeloid cells activated by toll-like receptor-4. PLoS One 12:e0179257
Wang D, D'Costa J, Civin CI, Friedman AD (2006) C/EBPalpha directs monocytic commitment of primary myeloid progenitors. Blood 108:1223–1229
Watari K, Shibata T, Kawahara A, Sata K, Nabeshima H, Shinoda A et al (2014) Tumor-derived interleukin-1 promotes lymphangiogenesis and lymph node metastasis through M2-type macrophages. PLoS One 9:e99568
Whitehurst B, Flister MJ, Bagaitkar J, Volk L, Bivens CM, Pickett B et al (2007) Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model. Int J Cancer 121:2181–2191
Yang H, Kim C, Kim MJ, Schwendener RA, Alitalo K, Heston W et al (2011) Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer. Mol Cancer 10:36
Yang Y, Chen XH, Li FG, Chen YX, Gu LQ, Zhu JK et al (2015) In vitro induction of human adipose-derived stem cells into lymphatic endothelial-like cells. Cell Reprogram 17:69–76
Zhang B, Zhang Y, Yao G, Gao J, Yang B, Zhao Y et al (2012) M2-polarized macrophages promote metastatic behavior of Lewis lung carcinoma cells by inducing vascular endothelial growth factor-C expression. Clinics (Sao Paulo) 67:901–906
Zhuo W, Jia L, Song N, Lu XA, Ding Y, Wang X et al (2012) The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis. Clin Cancer Res 18:5387–5398
Ziegler-Heitbrock HW, Ulevitch RJ (1993) CD14: cell surface receptor and differentiation marker. Immunol Today 14:121–125
Zlotnik A (2006) Involvement of chemokine receptors in organ-specific metastasis. Contrib Microbiol 13:191–199
Zumsteg A, Baeriswyl V, Imaizumi N, Schwendener R, Ruegg C, Christofori G (2009) Myeloid cells contribute to tumor lymphangiogenesis. PLoS One 4:e7067
Acknowledgments
The authors are grateful to Susan Ryherd for critical review and editing. This manuscript was supported by a grant # R01CA199649 awarded to Sophia Ran by the National Institutes of Health and a Team Science Grant from Simmons Cancer Institute funded by proceeds of the Denim and Diamonds charity event.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ran, S., Volk-Draper, L. (2020). Lymphatic Endothelial Cell Progenitors in the Tumor Microenvironment. In: Birbrair, A. (eds) Tumor Microenvironment. Advances in Experimental Medicine and Biology, vol 1234. Springer, Cham. https://doi.org/10.1007/978-3-030-37184-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-37184-5_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-37183-8
Online ISBN: 978-3-030-37184-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)